Skip to Content
 
Center for International Blood and Marrow Transplant Research

GV12-02

Main Content

Prognostic implications of acute upper gastrointestinal graft-versus-host disease in patients undergoing myeloablative hematopoietic cell transplantation.

Study #: GV12-02

Study Status: Published

Presentation(s)

2015, ASH (Oral)

Upper gastrointestinal acute graft- versus-host disease adds minimal prognostic value in isolation or with other graft- versus-host disease symptoms as currently diagnosed and treated.

Citation

Nikiforow S, Wang T, Hemmer M, Spellman S, Akpek G, Antin JH, Choi SW, Inamoto Y, Khoury HJ, MacMillan M, Marks DI, Meehan K, Nakasone H, Nishihori T, Olsson R, Paczesny S, Przepiorka D, Reddy V, Reshef R, Schoemans H, Waller N, Weisdorf D, Wirk B, Horowitz M, Alousi A, Couriel D, Pidala J, Arora M, Cutler C.

Haematologica. 2018, Oct 01: 103(10): 103(10):1708-1719. doi: 10.3324/haematol.2017.182550. Epub 2018, Aug 03. PMCID:PMC6165812.

PubMed

PMID: 30076185

Abstract